2019
Endocrine Therapy–Related Symptoms and Quality of Life in Female Cancer Survivors in the Yale Fitness Intervention Trial
Park S, Knobf M, Jeon S. Endocrine Therapy–Related Symptoms and Quality of Life in Female Cancer Survivors in the Yale Fitness Intervention Trial. Journal Of Nursing Scholarship 2019, 51: 317-325. PMID: 30874369, DOI: 10.1111/jnu.12471.Peer-Reviewed Original ResearchMeSH KeywordsAgedAromatase InhibitorsBreast NeoplasmsCancer SurvivorsExercise TherapyFatigueFemaleHumansMiddle AgedQuality of LifeTamoxifenConceptsFemale cancer survivorsQuality of lifeTherapy-related symptomsExercise intervention groupAromatase inhibitorsEndocrine therapyCancer survivorsExercise interventionIntervention groupBreast Cancer Prevention Trial Symptom ChecklistFunctional assessmentControl groupCancer Therapy-Endocrine SubscalePrevious large clinical trialsEndocrine therapy groupMild symptom distressCancer Therapy-GeneralExercise control groupLarge clinical trialsAdjuvant chemotherapyAdjuvant therapyHormonal therapyExercise groupIntervention trialsWeight management
2016
Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy
Knobf MT, Jeon S, Smith B, Harris L, Kerstetter J, Thompson AS, Insogna K. Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy. Breast Cancer Research And Treatment 2016, 155: 491-500. PMID: 26850265, DOI: 10.1007/s10549-016-3693-3.Peer-Reviewed Original ResearchConceptsFemale cancer survivorsPhysical activity groupEndocrine therapyBone outcomesExercise interventionBone lossFemoral neckAromatase inhibitorsActivity groupAdjuvant AI therapyChemotherapy-induced menopauseSufficient serum levelsAdjuvant endocrine therapyVitamin D supplementsHealthy postmenopausal womenLess bone lossHome-based groupSignificant BMD lossSignificant clinical problemMajority of subjectsAI therapyD supplementsPostmenopausal womenBMD lossBMD outcomes